VIPR1 and atherosclerosis: Moreover, to definitively decipher the receptor-specific mechanisms, it will be necessary to investigate the effects of these agonists/antagonists on atherosclerosis development and progression and plaque associated chondrogenesis in ApoE-/- mice of single or double VPAC1- and/or VPAC2-deficiencies in these animal models.